Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -29.32x is in line with its 5-year average of -28.24x, near the high end of its 5-year range (-171.09x–-17.77x).
6.65% below its 12-month average of -27.49x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -29.76x.
INTEREST COVERAGE RATIO
-29.32x
INTEREST COVERAGE RATIO AVG TTM
-27.49x
INTEREST COVERAGE RATIO AVG 3Y
-28.24x
INTEREST COVERAGE RATIO AVG 5Y
-28.24x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-6.65%
CURRENT VS 3Y AVG
-3.83%
CURRENT VS 5Y AVG
-3.83%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-2.21x
median of 261 covered companies
CURRENT VS SECTOR MEDIAN
-1226.70%
vs the sector median at left
Acumen Pharmaceuticals, Inc.
Market Cap
$153.84M
Interest Coverage Ratio
-29.32x
TTM Avg
-27.49x
3Y Avg
-28.24x
5Y Avg
-28.24x
Market Cap
$152.45M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$152.16M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$149.51M
Interest Coverage Ratio
-7.96x
TTM Avg
23.57x
3Y Avg
23.57x
5Y Avg
23.57x
Market Cap
$162.82M
Interest Coverage Ratio
-64.93x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$142.49M
Interest Coverage Ratio
-8.06x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$142.11M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$134.74M
Interest Coverage Ratio
-0.80x
TTM Avg
1.46x
3Y Avg
2.93x
5Y Avg
2.25x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Acumen Pharmaceuticals, Inc. (ABOS) | $153.84M | -29.32x | -27.49x | -28.24x | -28.24x |
| Anavex Life Sciences Corp. (AVXL)vs › | $152.45M | N/A | N/A | N/A | N/A |
| Cardiol Therapeutics Inc. (CRDL)vs › | $152.16M | N/A | N/A | N/A | N/A |
| Codexis, Inc. (CDXS)vs › | $149.51M | -7.96x | 23.57x | 23.57x | 23.57x |
| ALX Oncology Holdings Inc. (ALXO)vs › | $162.82M | -64.93x | N/A | N/A | N/A |
| Fortress Biotech, Inc. (FBIOP)vs › | $142.49M | -8.06x | N/A | N/A | N/A |
| Alpha Cognition Inc (ACOG)vs › | $142.11M | N/A | N/A | N/A | N/A |
| Freenome, Inc. (FRNM)vs › | $137.29M | N/A | N/A | N/A | N/A |
| AirSculpt Technologies, Inc. (AIRS)vs › | $134.74M | -0.80x | 1.46x | 2.93x | 2.25x |
| Compass Therapeutics, Inc. (CMPX)vs › | $172.99M | N/A | N/A | N/A | N/A |
Interest Coverage
-29.3x
Debt/Equity
0.55
Current Ratio
2.47
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -29.76x |
| 2026-03-31 | -19.78x |
| 2025-12-31 | -23.18x |
| 2025-09-30 | -24.82x |
| 2025-06-30 | -39.91x |
| 2025-03-31 | -29.69x |
| 2024-12-31 | -38.18x |
| 2024-09-30 | -31.42x |
| 2024-06-30 | -24.28x |
| 2024-03-31 | -17.77x |
| 2023-12-31 | -31.82x |
| 2021-09-30 | -171.09x |
